Literature DB >> 28296146

Epidemiology of uterine fibroids: a systematic review.

E A Stewart1, C L Cookson2, R A Gandolfo2, R Schulze-Rath3.   

Abstract

BACKGROUND: Uterine fibroids (UFs) are the most common neoplasm affecting women that can cause significant morbidity and may adversely impact fertility.
OBJECTIVES: To examine UF epidemiology and to evaluate the relative strengths of putative risk factors. SEARCH STRATEGY: MEDLINE and Embase were searched for studies published in English between January 1995 and April 2015. SELECTION CRITERIA: Publications reporting relevant data from registries and other observational studies with over 1000 patients and single-centre studies with over 100 patients were selected. DATA COLLECTION AND ANALYSIS: Data on UF incidence, prevalence and associated risk factors were extracted from 60 publications. MAIN
RESULTS: Wide ranges were reported in both UF incidence (217-3745 cases per 100 000 women-years) and prevalence (4.5-68.6%), depending on study populations and diagnostic methods. Black race was the only factor that was recurrently reported to increase UF risk, by two-threefold compared with white race. Eleven other factors affected UF risk to a magnitude similar to or greater than race. Age, premenopausal state, hypertension, family history, time since last birth, and food additive and soybean milk consumption increased UF risk; use of oral contraceptives or the injectable contraceptive depot medroxyprogesterone acetate, smoking in women with low body mass index and parity reduced UF risk.
CONCLUSIONS: We identified 12 risk factors that play an important role in UF epidemiology. The UF risk factor with the strongest evidence is black race. High-quality prospective observational data are needed to improve our understanding of UF epidemiology, and thus its aetiology and optimal management. TWEETABLE ABSTRACT: Uterine fibroids occur in about 70% of women. Black race and 11 other factors affect uterine fibroid risk.
© 2017 IPAS. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Epidemiology; incidence; leiomyoma; prevalence; race; risk factors; uterine fibroids

Mesh:

Year:  2017        PMID: 28296146     DOI: 10.1111/1471-0528.14640

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  123 in total

1.  Blastocyst formation rate for Asians versus Caucasians and within body mass index categories.

Authors:  Rucha Khunte; Mengmeng Li; Barry Behr; Qianying Zhao; Valerie Lynn Baker
Journal:  J Assist Reprod Genet       Date:  2020-03-04       Impact factor: 3.412

2.  Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.

Authors:  Erica E Marsh; Ayman Al-Hendy; Dale Kappus; Alex Galitsky; Elizabeth A Stewart; Majid Kerolous
Journal:  J Womens Health (Larchmt)       Date:  2018-09-19       Impact factor: 2.681

3.  Moving Toward Individualized Medicine for Uterine Leiomyomas.

Authors:  Shannon K Laughlin-Tommaso; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

4.  Racial and Socioeconomic Disparities in Hysterectomy Route for Benign Conditions.

Authors:  Amin Sanei-Moghaddam; Chaeryon Kang; Robert P Edwards; Paula J Lounder; Naveed Ismail; Sharon L Goughnour; Suketu M Mansuria; John T Comerci; Faina Linkov
Journal:  J Racial Ethn Health Disparities       Date:  2017-08-24

5.  Drug-Drug Interaction Studies of Elagolix with Oral and Transdermal Low-Dose Hormonal Add-Back Therapy.

Authors:  Ahmed Nader; Nael M Mostafa; Farah Ali; Mohamad Shebley
Journal:  Clin Pharmacokinet       Date:  2021-01       Impact factor: 6.447

6.  Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).

Authors:  Ussanee S Sangkomkamhang; Pisake Lumbiganon; Porjai Pattanittum
Journal:  Cochrane Database Syst Rev       Date:  2020-11-23

7.  Haplotypes of CYP1B1 and CCDC57 genes in an Afro-Caribbean female population with uterine leiomyoma.

Authors:  Angela T Alleyne; Virgil S Bideau
Journal:  Mol Biol Rep       Date:  2019-04-13       Impact factor: 2.316

8.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

9.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

10.  Comparison of safety and efficacy between laparoscopic myomectomy and traditional laparotomy for patients with uterine fibroids and their effect on pregnancy rate after surgery.

Authors:  Xueqiao Kan; Xiaoxia Shen; Li Feng; Yuqing Hu; Jiadong Yu; Xiaoju Yang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.